| Study | Reason for exclusion |
|---|---|
| Abdel Kader 2017 | Target condition was hepatic focal lesions with differentiation between benign and malignant lesions. No data on per‐patient analysis. |
| Akhtar 2020 | 2 × 2 table was not reported directly and could not be calculated/extracted based on the reported data. |
| Araki 2000 | Editorial. |
| Aubé 2017 | Study population included > 5% of participants previously treated for HCC. No data on per‐patient analysis. |
| Ayuso 2019 | No data on per‐patient analysis. |
| Baird 2013 | No data on per‐patient analysis. |
| Barabino 2021 | Study assessed the accuracy of LI‐RADS features, no data on per‐patient analysis reported, and no data on accuracy of MRI alone. |
| Bartolozzi 2013 | No data on per‐patient analysis. |
| Basha 2018 | No data on per‐patient analysis. |
| Becker‐Weidman 2011 | Study population included > 5% of participants previously treated for HCC. |
| Blondin 2011 | No data on per‐patient analysis. |
| Burrel 2003 | Study included participants with previously known HCC. |
| Choi 2008 | Study population included > 5% of participants previously treated for HCC. |
| Chou 2014 | No data on per‐patient analysis. |
| Clarke 2021 | No data on per‐patient analysis. |
| Compagnon 2008 | Study population included > 5% of participants previously treated for HCC. The 2 × 2 table was not reported directly and could not be calculated/extracted based on the data that were reported. |
| Debees 2016 | Target condition was differentiation of benign versus malignant lesions. No data on per‐patient analysis. |
| Ercalli 2013 | No data on per‐patient analysis. |
| Faletti 2015 | Study included participants with previously known HCC. |
| Fischer 2015 | Study assessed the accuracy of MRI imaging features for the diagnosis of HCC. |
| Forner 2008 | Participant data set was included in Darnell 2021. |
| Forner 2018b | Participant data set was included in Darnell 2021. |
| Forner 2019 | Study assessed the accuracy of LI‐RADS criteria. |
| Giorgio 2005 | Study included the same participant population as Giorgio 2007. |
| Guiu 2008 | 2 × 2 table was not reported directly and could not be calculated/extracted based on the reported data. |
| Guo 2012 | 2 × 2 table was not reported directly and could not be calculated/extracted based on the reported data. No data on per‐patient analysis. |
| Hanna 2014 | Study population included > 5% of participants previously treated for HCC. |
| Hardie 2010 | Study included participants with previously known HCC. |
| Hardie 2011a | Participant data set was included in Hardie 2011b. No data on per‐patient analysis. |
| Hardie 2011b | No data on per‐patient analysis. |
| Hecht 2006 | No data on per‐patient analysis. |
| Heilmaier 2008 | No data on per‐patient analysis. |
| Heilmaier 2009 | No data on per‐patient analysis. |
| Ichikawa 2021 | No data on per‐patient analysis. |
| Kang 2012 | 2 × 2 table was not reported directly and could not be calculated/extracted based on the reported data. |
| Kim 2011 | No data on per‐patient analysis. |
| Kim 2012 | No data on per‐patient analysis. |
| Kim 2021 | Study included participants with previously known HCC. |
| Kondo 2000 | Study included participants with previously known HCC. |
| Lee 2021 | Study included participants with previously known HCC. |
| Li 2015 | No data on per‐patient analysis. |
| Li 2018 | Study included participants with previously known HCC. |
| Li 2021 | No data on per‐patient analysis. |
| Macarini 2006 | No data on per‐patient analysis. 2 × 2 table was not reported directly and could not be calculated/extracted based on reported data. |
| Macarini 2009 | No data on per‐patient analysis. 2 × 2 table was not reported directly and could not be calculated/extracted based on reported data. |
| Mann 2001 | No data on per‐patient analysis. 2 × 2 table was not reported directly and could not be calculated/extracted based on reported data. |
| Matsuo 2001 | No data on per‐patient analysis. |
| Maurea 2014 | Target condition was focal liver lesions, not HCC in particular. |
| Mehra 2012 | Target condition was focal liver lesions (benign versus malignant lesions). No data on per‐patient analysis. |
| Miller 2008 | Narrative review. |
| Min 2018b | No data on per‐patient analysis. |
| Mita 2010 | No data on per‐patient analysis. |
| Moon 2018 | No data on per‐patient analysis. |
| Mori 2002 | No data on per‐patient analysis for the accuracy of MRI for HCC. |
| Obuz 2006 | Target condition was malignant liver lesions, not HCC in particular. |
| Pahade 2016 | Study population included > 5% of participants previously treated for malignant lesions in general. |
| Paisant 2020 | Study population included > 5% of participants previously treated for HCC. No data on per‐patient analysis. |
| Park 2012 | Study population included > 5% of participants previously treated for HCC. |
| Park 2020 | No data on per‐patient analysis. |
| Phongkitkarun 2013 | No data on per‐patient analysis. |
| Puig 1997 | No data on per‐patient analysis. |
| Qayyum 2006 | No data on per‐patient analysis. |
| Rimola 2012 | Patient data set is included in Darnell 2021. |
| Rofsky 1993 | No data on per‐patient analysis. |
| Samoylova 2018 | Study included participants with previously known HCC. |
| Serste 2010 | Participants included in Sersté 2012. |
| Shankar 2016 | 2 × 2 table was not reported directly and could not be calculated/extracted based on reported data. |
| Simon 2005 | No data on per‐patient analysis. |
| Snowberger 2007 | Study included participants with previously known HCC. |
| Stocker 2018 | 2 × 2 table was not reported directly and could not be calculated/extracted based on reported data. |
| Suárez‐Muñoz 2006 | 2 × 2 table was not reported directly and could not be calculated/extracted based on reported data. |
| Sugimoto 2015 | 2 × 2 table was not reported directly and could not be calculated/extracted based on reported data. |
| Teerasamit 2017 | No data on per‐patient analysis. |
| Timofte 2016 | 2 × 2 table was not reported directly and could not be calculated/extracted based on reported data. |
| Tsang 2011 | Target condition included malignant hepatic lesions, not HCC in particular. |
| Ueda 1995 | No data on per‐patient analysis. |
| Vandecaveye 2009 | No data on per‐patient analysis. |
| van Wettere 2019 | No data on per‐patient analysis. |
| Xu 2009 | No data on per‐patient analysis. |
| Xu 2013 | 2 × 2 table was not reported directly and could not be calculated/extracted based on reported data. |
| Yoo 2008 | 2 × 2 table was not reported directly and could not be calculated/extracted based on reported data. |
| Zhao 2014 | 2 × 2 table was not reported directly and could not be calculated/extracted based on reported data. |
| Zhong 2020 | Study included participants with previously known HCC. |
HCC: hepatocellular carcinoma; LI‐RADS (criteria): Liver Imaging Reporting and Data System criteria; MRI: magnetic resonance imaging.